GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...

Together, ZF and Qualcomm Technologies aim to deliver a future-proof ADAS compute platform that supports the rapid advancement of automated driving, enhances vehicle safety, and aligns with the ...